Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: Values in healthy adults

European Respiratory Journal

Volumn 30, Issue 4, 2007, Pages 769-781

  Balbi, B ^a   Pignatti, P ^a   Corradi, M ^c   Baiardi, P ^b   Bianchi, L ^a   Brunetti, G ^a   Radaeli, A ^d   Moscato, G ^a   Mutti, A ^c   Spanevello, A ^a,e   Malerba, M ^d  

^a IRCCS   (Italy)

^b Consortium for Biological and Pharmacological Evaluation ^*  (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Airway inflammation; Bronchoalveolar lavage; Exhaled breath condensate; Induced sputum; Nitric oxide; Normal values

Indexed keywords

BIOLOGICAL MARKER; NITRIC OXIDE;

BREATH ANALYSIS; BREATHING; CELL COUNT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DILUTION; DISEASE COURSE; EOSINOPHIL COUNT; ETHICS; EXHALATION; HUMAN; INFLAMMATION; LUNG LAVAGE; LYMPHOCYTE COUNT; MEDIATOR; MEDICAL RESEARCH; NEUTROPHIL COUNT; NORMAL VALUE; PRIORITY JOURNAL; REVIEW; SMOKING; SPUTUM ANALYSIS; VOLUNTEER; ADOLESCENT; ADULT; AGED; FEMALE; MALE; METABOLISM; MIDDLE AGED; REFERENCE VALUE; SPUTUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHOALVEOLAR LAVAGE; EXHALATION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRIC OXIDE; REFERENCE VALUES; SPUTUM;

EID: 38449086102     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00112306     Document Type: Review

References (101)

1. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989; 2: 561-585.
2. Klech H, Hutter C, Costabel U, eds. Clinical guidelines and indications for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group on BAL. Eur Respir Rev 1992; 2: 47-127.
3. Haslam PL, Baughmann RP, eds. Guidelines for measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Report of the European Respiratory Society Task Force. Eur Respir Rev 1999; 9: 25-157.
4. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE, eds. Standardised methodology of sputum induction and processing. Eur Resp J 2002; 20: Suppl. 37, 1s-55s.
5. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
6. Horvath I, Hunt J, Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
7. Reynolds HY. Use of bronchoalveolar lavage in humans - past necessity and future imperative. Lung 2000; 178: 271-293.
8. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Am J Respir Crit Care Med 1999; 160: 736-755.
9. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. American Thoracic Society (ATS) and European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
10. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 2002; 121: 1051-1057.
11. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophils counts: a randomized controlled trial. Lancet 2002; 360: 1715-1721.
12. Jayaram L, Parameswaran K, Sears MR, Hargreave FE. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000; 16: 150-158.
13. Sterk PJ, Hargreave FE, Kips JC, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J 2002; 20: Suppl. 37, 40s-43s.
14. Brightling CE. Clinical applications of induced sputum. Chest 2006; 129: 1344-1348.
15. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma, 2006. www.ginasthma.com Date last accessed: March 2007.
16. Deykin A, Massaro AF, Drazen JM, Israel E. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med 2002; 165: 1597-1601.
17. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169: 473-478.
18. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New Engl J Med 2005; 352: 2163-2173.
19. Taylor Dr, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006; 61: 817-827.
20. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006; 130: 1541-1546.
21. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559-573.
22. Wooten OJ, Dulfano MJ. Improved homogenization techniques for sputum cytology counts. Ann Allergy 1978; 41: 150-154.
23. Gustaffson LE, Leone AM, Persson MG, Wiklund NP, Moncanda S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-857.
24. Sidorenko GI, Zborovskii EI, Levina DI. Surface-active properties of the exhaled air condensate (a new method of studying lung function). Ter Arkh 1980; 52: 65-68.
25. Ettenshon DB, Jankowski MJ, Redondo AA, Duncan PG. Bronchoalveolar lavage in the normal volunteer subject. 2. Safety and results of repeated BAL and use in the assessment of intrasubject variability. Chest 1988; 94: 281-285.
26. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1990; 141: S169-S201.
27. Von Essen SG, Robbins RA, Spurzem JR, Thompson AB, McGranaghan SS, Rennard SI. Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis 1991; 144: 848-854.
28. Warr GA, Martin RR, Holleman CI, Criswell BS. Classification of bronchial lymphocytes from nonsmokers and smokers. Am Rev Respir Dis 1978; 113: 96-100.
29. Laviolette M. Lymphocyte fluctuation in bronchoalveolar lavage fluid in normal volunteers. Thorax 1985; 40: 651-656.
30. Ettensohn DB, Jankowski MJ, Duncan PG, Lalor PA. Bronchoalveolar lavage in the normal volunteer subject. I. Technical aspects and intersubject variability. Chest 1988; 94: 275-280.
31. Merchant RK, Schwartz DA, Helmers RA, Dayton CS, Hunnighake GW. Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis 1992; 146: 448-453.
32. Everson RB, Schreinemachers DM, Devlin RB, Koren HS. Host determinants of cellular and biochemical constituents of bronchoalveolar lavage fluids. Implications for design of epidemiologic studies. Am J Respir Crit Care Med 1994; 149: 899-904.
33. Meyer KC, Ershler W, Rosenthal NS, Lu X, Peterson K. Immune disregulation in the aging human lung. Am J Respir Crit Care Med 1996; 153: 1072-1079.
34. Meyer KC, Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax 1999; 54: 697-700.
35. Ekberg-Jansson A, Andersson B, Arva E, Nilsson O, Lofdahl CG. The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells in healthy smoking and never-smoking men, 60 years old. Respir Med 2000; 94: 264-272.
36. Holz O, Richter K, Jorres RA, Speckin P, Mucke M, Magnussen H. Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998; 53: 83-86.
37. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
38. Pignatti P, Delmastro M, Perfetti L, et al. Is dithiothreitol affecting cells and soluble mediators during sputum processing? A modified methodology to process sputum. J Allergy Clin Immunol 2002; 110: 667-668.
39. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120: 1917-1922.
40. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
41. Belda J, Leigh R, Parameswaran K, O'Byrne P, Sears MR, Hargreave FE. Induced sputum cell in healthy adults. Am J Respir Crit Care Med 2000; 161: 475-478.
42. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000; 162: 1172-1174.
43. Thomas RA, Green RH, Brightling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004; 126: 1811-1814.
44. Olin AC, Rosengren A, Thelle D, Lissner L, Bjorn Bake, Torén K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006; 130: 1319-1325.
45. Haight RR, Gordon RL, Brooks SM. The effects of age on exhaled nitric oxide levels. Lung 2006; 184: 113-119.
46. Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (revFENO) study. Respir Res 2006; 7: 94s.
47. Malerba M, Balbi B, Spanevello A. Aging and sputum cells. Chest 2005; 128: 4049-4050.
48. Nightingale JA, Maggs R, Cullinan P, et al. Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med 2000; 162: 161-166.
49. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722.
50. Silkoff P, McClean P, Slutsky A, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155: 260-267.
51. Lundberg, J, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-373.
52. Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153: 1773-1780.
53. Muller KC, Jorres RA, Magnussen H, Holz O. Comparison of exhaled nitric oxide analysers. Respir Med 2005; 99: 631-637.
54. Jilma B, Kastner J, Mensik C, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci 1996; 58: 469-476.
55. Van der Lee I, Van der Bosch JMM, Zanen P. Reduction of variability of exhaled nitric oxide in healthy volunteers. Respir Med 2002; 96: 1014-1020.
56. Morris NH, Sooranna SR, Steer PJ, Warren JB. The effect of the menstrual cycle on exhaled nitric oxide and urinary nitrate concentration. Eur J Clin Invest 1996; 26: 481-484.
57. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999; 159: 311-314.
58. Hacken NH, Van der Waart M, Van der Mark TW, Koeter GH, Postma DS. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Resp Crit Care Med 1998; 158: 902-907.
59. Ekroos H, Karajalainen J, Sarna S. Short term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. Respir Med 2002; 96: 895-900.
60. Maniscalco M, Weitzberg E, Sundberg J, Sofia M, Lundberg JO. Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations. Eur Respir J 2003; 22: 323-329.
61. Grasemann H, Drazen JM, Deykin A, et al. Simple tandem repeat polymorphisms in the neuronal nitric oxide synthase gene in different ethnic populations. Hum Hered 1999; 49: 139-141.
62. Hansel TT, Kharitonov SA, Donnelly LE, et al. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 2003; 17: 1298-1300.
63. McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, Benjamin N. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut 1997; 40: 211-214.
64. Kharitonov SA, Yates DH, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory infections. Eur Respir J 1995; 8: 295-297.
65. Runer T, Cervin A, Lindberg S, Uddman R. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 1998; 119: 278-287.
66. Sumino H, Nakamura T, Kanda T, et al. Effect of enalapril on exhaled nitric oxide in normotensive and hypertensive subjects. Hypertension 2000; 36: 934-940.
67. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152: 892-896.
68. Phillips CR, Giraud GD, Holden WE. Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J Appl Physiol 1996; 80: 1865-1871.
69. Bruce C, Yates DH, Thomas PS. Caffeine decreases exhaled nitric oxide. Thorax 2002; 57: 361-363.
70. Kharitonov SA, Robbins RA, Yates DH, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152: 609-612.
71. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J 1996; 9: 1130-1133.
72. Marteus H, Mavropoulos A, Palm JP Ulfgren AK, Bergstrom J, Alving K. Nitric oxide formation in the oropharyngeal tract: possible influence of cigarette smoking. Nitric Oxide 2004; 11: 247-255.
73. Chambers DC, Tunnicliffe WS, Ayres JG. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 1998; 53: 677-679.
74. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. Allergy 2001; 56: 813-824.
75. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21: 433-438.
76. Van der Lee I, Van der Bosch JMM, Zanen P. Reduction of variability of exhaled nitric oxide in healthy volunteers. Respir Med 2002; 96: 1014-1020.
77. Goldoni M, Caglieri A, Andreoli R, et al. Influence of condensation temperature on selected exhaled breath parameters. BMC Pulm Med 2005; 5: 10.
78. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30: 178-186.
79. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389-396.
80. Szkudlarek U, Maria L, Kasielski M, Kaucka S, Nowak D. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 2003; 97: 718-725.
81. Svensson S, Olin AC, Larstad M, Ljungkvist G, Toren K. Determination of hydrogen peroxide in exhaled breath condensate by flow injection analysis with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 809: 199-203.
82. Montuschi P, Barnes PJ, Roberts LJ 2nd. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004; 18: 1791-1800.
83. Ko FW, Lau CY, Leung TF, Wong GW, Lam CW, Hui DS. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir Med 2006; 100: 630-638.
84. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004; 59: 1016-1019.
85. Carpagnano GE, Resta O, Foschino-Barbaro MP, et al. Exhaled interleukin-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 2004; 505: 169-175.
86. Carpagnano GE, Foschino Barbaro MP, Cagnazzo M, et al. Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest 2005; 128: 3159-3166.
87. Paget-Brown AO, Ngamtrakulpanit L, Smith A, et al. Normative data for pH of exhaled breath condensate. Chest 2006; 129: 426-430.
88. Borrill Z, Starkey C, Vestbo J, Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 269-274.
89. Vaughan J, Ngamtrakulpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003; 22: 889-894.
90. Corradi M, Pignatti P, Manini P, et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J 2004; 24: 1011-1017.
91. Goldoni M, Catalani S, De Palma G, et al. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect 2004; 112: 1293-1298.
92. Mutti A, Corradi M, Goldoni M, Caglieri A, Vettori MV, Apostoli P. Sensitivity of exhaled biomarkers: a field study on acute and persistent changes among chromeplating workers. Am J Respir Crit Care Med 2005; 171: A673.
93. Majewska E, Kasielski M, Luczynski R, Bartosz G, Bialasiewicz P, Nowak D. Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. Respir Med 2004; 98: 669-676.
94. Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L. Occupational asthma and occupational rhinitis in hairdressers. Chest 2005; 128: 3590-3598.
95. Borrill ZL, Smith JA, Naylor J, Woodcock AA, Singh D. The effect of gas standardisation on exhaled breath condensate pH. Eur Respir J 2006; 28: 251-252.
96. Huszar E, Szabo Z, Jakab A, Barta I, Herjavecz I, Horvath I. Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays. Inflamm Res 2005; 54: 350-355.
97. Corradi M, Pignatti P, Goldoni M, et al. Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases. Eur Respir J 2006; 28: Suppl. 50, 828S.
98. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007; 175: 222-227.
99. Barnes PJ, Chowdhury B, Kharitonov SA, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 6-14.
100. Pizzichini MM, Pizzichini E, Efthimiadis A, et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998; 158: 1178-1184.
101. Jobsis RQ, Schellekens SL, Fakkel-Kroesbergen A, Raatgeep RH, de Jongste JC. Hydrogen peroxide in breath condensate during a common cold. Mediators Inflamm 2001; 10: 351-354.